Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
https://www.zacks.com/stock/news/2272792/why-cardinal-health-cah-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2272792
May 13, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
0
Compared to Estimates, Cardinal (CAH) Q3 Earnings: A Look at Key Metrics
https://www.zacks.com/stock/news/2267290/compared-to-estimates-cardinal-cah-q3-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2267290
May 02, 2024 - The headline numbers for Cardinal (CAH) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
0
What's in Store for These 5 Medical Device Stocks in Q1 Earnings?
https://www.zacks.com/stock/news/2266269/what-s-in-store-for-these-5-medical-device-stocks-in-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview_-_esp-2266269
May 01, 2024 - Here is a sneak peek into how five medical device stocks, BDX, BAX, XRAY, CAH and DVA, might fare in their quarterly results slated to be released tomorrow.
0
What's in Store for Cardinal Health (CAH) in Q3 Earnings?
https://www.zacks.com/stock/news/2264353/what-s-in-store-for-cardinal-health-cah-in-q3-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2264353
Apr 29, 2024 - Cardinal Health's (CAH) third-quarter fiscal 2024 results are expected to reflect solid performance in the Pharmaceutical and Specialty Solutions segment.
0
Factors Setting the Tone For Lantheus' (LNTH) Q1 Earnings
https://www.zacks.com/stock/news/2263589/factors-setting-the-tone-for-lantheus-lnth-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2263589
Apr 26, 2024 - Lantheus' (LNTH) first-quarter results are likely to reflect solid top-line performance on the back of robust product adoption.
0
Here's What You Should Know About EBAY Ahead of Q1 Earnings
https://www.zacks.com/stock/news/2263563/here-s-what-you-should-know-about-ebay-ahead-of-q1-earnings?cid=CS-ZC-FT-analyst_blog|most_popular_stocks-2263563
Apr 26, 2024 - EBAY's first-quarter 2024 performance will likely reflect strength across its advertising business amid softness in its active buyer base.
0
3 Medical Products Stocks Set to Beat This Earnings Season
https://www.zacks.com/stock/news/2263462/3-medical-products-stocks-set-to-beat-this-earnings-season?cid=CS-ZC-FT-earnings_esp-2263462
Apr 26, 2024 - Here are three stocks, TXG, CAH and HOLX, which are expected to beat earnings estimates in the ongoing reporting cycle.
0
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
https://www.zacks.com/stock/news/2263271/are-you-a-value-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2263271
Apr 26, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
0
ETSY Gears Up to Report Q1 Earnings: What's in the Cards?
https://www.zacks.com/stock/news/2262641/etsy-gears-up-to-report-q1-earnings-what-s-in-the-cards?cid=CS-ZC-FT-analyst_blog|earnings_preview-2262641
Apr 25, 2024 - ETSY's first-quarter 2024 earnings are likely to have gained from growing momentum among active buyers and active sellers.
0
Neurocrine launches CAH community website ahead of FDA filing
https://seekingalpha.com/news/4093768-neurocrine-launches-cah-community-website-ahead-of-fda-filing?source=feed_sector_healthcare
Apr 24, 2024 - Neurocrine (NBIX), which has developed a drug for congenital adrenal hyperplasia, has launched a new interactive website to support patients with the condition. Read more here.
0
Page 1>